Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Articles

Page Path
HOME > Diabetes Metab J > Volume 45(5); 2021 > Article
Corrigendum
Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
Jee Hee Yoo1, Jae Hyeon Kim2
Diabetes & Metabolism Journal 2021;45(5):795-795.
DOI: https://doi.org/10.4093/dmj.2021.0256
Published online: September 30, 2021
  • 3,798 Views
  • 105 Download
  • 1 Web of Science
  • 1 Crossref
  • 2 Scopus

1Division of Endocrinology and Metabolism, Department of Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea

2Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Copyright © 2021 Korean Diabetes Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next
This corrects the article "Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control" on page 828.
Diabetes & Metabolism Journal 2020;44:828-839. https://doi.org/10.4093/dmj.2020.0257
Fig. 1A of this manuscript has some error. The % next to the text “TAR”, “TBR”, and “TAR” should be changed to mg/dL.
We apologize for any inconvenience that this may have caused.
Fig. 1.
(A) Even in patients with the same glycosylated hemoglobin (HbA1c) or mean glucose, exact glycemic control may vary. For example, some patients can have excellent glycemic control, spending the whole day with glucose levels between 70 and 180 mg/dL; on the other hand, some patients’ glucose levels may range from 50 to 250 mg/dL. (B) Self-monitoring blood glucose (SMBG) cannot fully capture actual glycemic fluctuation like continuous glucose monitoring (CGM) measuring interstitial glucose level every 5 to 15 minutes (96 to 288 measurements/day). TAR, time above range; TBR, time below range; TIR, time in range.
dmj-2021-0256f1.jpg

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Glycemia Risk Index is Associated With Risk of Albuminuria Among Individuals With Type 1 Diabetes
      Ji Yoon Kim, Jee Hee Yoo, Nam Hoon Kim, Jae Hyeon Kim
      Journal of Diabetes Science and Technology.2025;[Epub]     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite this Article
      Cite this Article
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
      Diabetes Metab J. 2021;45(5):795-795.   Published online September 30, 2021
      Close
    • XML DownloadXML Download
    Figure
    • 0
    Related articles
    Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
    Image
    Fig. 1. (A) Even in patients with the same glycosylated hemoglobin (HbA1c) or mean glucose, exact glycemic control may vary. For example, some patients can have excellent glycemic control, spending the whole day with glucose levels between 70 and 180 mg/dL; on the other hand, some patients’ glucose levels may range from 50 to 250 mg/dL. (B) Self-monitoring blood glucose (SMBG) cannot fully capture actual glycemic fluctuation like continuous glucose monitoring (CGM) measuring interstitial glucose level every 5 to 15 minutes (96 to 288 measurements/day). TAR, time above range; TBR, time below range; TIR, time in range.
    Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
    Yoo JH, Kim JH. Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control. Diabetes Metab J. 2021;45(5):795-795.
    DOI: https://doi.org/10.4093/dmj.2021.0256.

    Diabetes Metab J : Diabetes & Metabolism Journal
    Close layer
    TOP